A multi-centre, randomised, double blind, placebo-controlled, parallel group, phase IIa clinical trial to assess the efficacy and safety of Cpn10 administered as twice weekly subcutaneous injections in subjects with Rheumatoid Arthritis.
Phase of Trial: Phase II
Latest Information Update: 08 Jun 2016
At a glance
- Drugs INV 103 (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Nov 2011 Results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 09 Nov 2011 Status changed from active, no longer recruiting to completed.
- 03 Feb 2011 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry.